Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALLET: Neoadjuvant palbociclib + letrozole in postmenopausal ER+ breast cancer
2014-000887-16Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Letrozole alone with Palbociclib + letrozole (2 arms). Primary endpoints: Change in Ki67 proliferation index and Clinical tumor response. Started Mar 2015; status: completed.
02
Drugs
palbociclibletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2014-000887-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000887-16.